News about Solvay

  • Local
  • International
  • Company messages
24 Sep
19 Sep
12 Sep
31 Jul
25 May
22 May
11 May
08 May
03 May
11 Apr
06 Apr
04 Apr
29 Mar
28 Mar
23 Mar
20 Mar
28 Feb
21 Feb
16 Feb
15 Feb

Popular news

Teenager’s Lifesaving TickTracker App Recognized by Department of Health & Human Services
Pomerantz Law Firm Announces the Filing of a Class Action against OPKO Health, Inc. and Certain Officers – OPK
Novartis to file for new Lucentis® (ranibizumab) indication in retinopathy of prematurity (ROP), a rare disease in premature infants that often leads to blindness
Nightstar Reports Positive Proof of Concept Data from Dose Escalation Study in XIRIUS Trial for NSR-RPGR in XLRP Patients
New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD
Plexus Celebrates the Opening of the Enhanced Penang Design Center
CADWorx® & Analysis Solutions releases new CADWorx Design Review Professional for model visualization and publishing
Youth INC and RBC Host Fourth Annual Community Event and Raise $1.7M for NYC Youth
Melinta Therapeutics Receives Positive CHMP Opinion for Vabomere™ (meropenem and vaborbactam)
PHILIP MORRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Philip Morris International Inc. - PM

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
26 September 2018 05:56:31
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180919.1 - EUROWEB1 - 2018-09-26 06:56:31 - 2018-09-26 05:56:31 - 1000 - Website: OKAY